Fraunhofer Research Institution for Individualized Medical Technology and Engineering IMTEAI-supported follow-up care for young adults with increased cardiac risk
About
CardioHope develops a digital solution for long-term health monitoring in young adults who were diagnosed with Hodgkin lymphoma during childhood or adolescence. A smartwatch continuously collects activity and health data, which are analyzed using AI to provide personalized recommendations aimed at strengthening the cardiovascular system.
Opportunity
Survivors of childhood or adolescent Hodgkin lymphoma face an increased lifetime risk of cardiovascular diseases due to earlier cancer treatments. Conventional follow-up care often provides only isolated snapshots and fails to capture individual activity levels, daily fluctuations, and subtle health changes. As a result, risk factors for late effects may go unnoticed—precisely when this group needs continuous support.
Solution/Product description
Within CardioHope, a smartwatch continuously records relevant activity and health parameters. AI-based data analysis generates a personalized health profile and tailored recommendations to improve cardiovascular fitness and daily physical activity. A comprehensive intervention study evaluates the long-term impact of this digital follow-up approach on cardiac health.
Why Us
CardioHope integrates modern wearable technology with expertise from sports science and cardio-oncology. The combination of continuous data collection, AI-driven analysis, and individualized guidance provides clear advantages over traditional follow-up strategies. The insights gained can also benefit other patient groups at elevated risk and serve as a foundation for future digital health applications.
